Aaron Prodeus Selected Research

T-Cell Antigen Receptors (T-Cell Receptor)

1/2022

CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aaron Prodeus Research Topics

Disease

7	Neoplasms (Cancer) 01/2022 - 08/2014
2	Arthritis (Polyarthritis) 01/2022 - 08/2014
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 10/2018
2	Inflammation (Inflammations) 09/2018 - 08/2014
1	Wilms Tumor (Wilm's Tumor) 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Knee Osteoarthritis 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Hepatitis 01/2017
1	Epilepsy (Aura) 01/2017
1	Heart Diseases (Heart Disease) 01/2017
1	Huntington Disease (Huntington's Disease) 01/2017
1	Melanoma (Melanoma, Malignant) 04/2015
1	Hypersensitivity (Allergy) 08/2014
1	Infections 08/2014
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2014
1	Multiple Sclerosis 08/2014

Drug/Important Bio-Agent (IBA)

2	Nucleotide AptamersIBA 01/2022 - 04/2015
2	AntigensIBA 01/2022 - 01/2016
2	LigandsIBA 01/2016 - 08/2014
2	AntibodiesIBA 01/2016 - 04/2015
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2022
1	EpitopesIBA 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	HLA-A Antigens (HLA-A)IBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	liposomal doxorubicin (Doxil)FDA Link 01/2020
1	Therapeutic UsesIBA 01/2020
1	EnzymesIBA 01/2019
1	Carcinoembryonic AntigenIBA 10/2018
1	Fibronectins (Fibronectin)IBA 10/2018
1	Biomarkers (Surrogate Marker)IBA 10/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 09/2018
1	LipidsIBA 01/2017
1	Concanavalin AIBA 01/2017
1	Poly I-CIBA 01/2016
1	Interleukin-9 (Interleukin 9)IBA 01/2016
1	Angiopoietin-1IBA 06/2015
1	VasculotideIBA 06/2015

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2019
2	Immunotherapy 01/2022 - 01/2019
1	Transplantation 08/2014